Company Comparison
Juno Therapeutics vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Juno Therapeutics | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | San Diego |
| Founded | 2013 | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | $300M | $48M |
| Valuation | — | — |
What They Build
Juno Therapeutics
Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Juno Therapeutics
AI Therapeutics
No investors listed.
Sector Overlap
Both Juno Therapeutics and AI Therapeutics operate in Biotech.
Browse all Biotech companies →